Headache < Health Care Costs < Health Care Surveys

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Health Care Costs

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
000F92 (2019)	Ibrahim Khilfeh ; Eric Guyette [États-Unis] ; John Watkins [États-Unis] ; Dan Danielson [États-Unis] ; David Gross [États-Unis] ; Kai Yeung	Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study.
001435 (2018)	Tao Gu [États-Unis] ; Alex Mutebi ; Bradley S. Stolshek ; Hiangkiat Tan	Cost of biologic treatment persistence or switching in rheumatoid arthritis.
001784 (2017)	Anagha Nadkarni [États-Unis] ; Donna Mcmorrow [États-Unis] ; Chad Patel [États-Unis] ; Robert Fowler [États-Unis] ; David Smith [États-Unis]	Incidence of dose escalation and impact on biologic costs among patients with rheumatoid arthritis treated with three intravenous agents.
001B92 (2016)	Alberto Batticciotto [Italie] ; Roberto Ravasio [Italie] ; Marta Riva [Italie] ; Piercarlo Sarzi-Puttini [Italie]	Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate.
001C89 (2016)	Benjamin Chastek [États-Unis] ; John White [États-Unis] ; Damon Van Voorhis [États-Unis] ; Derek Tang [États-Unis] ; Bradley S. Stolshek [États-Unis]	A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients.
002073 (2015)	Eiichi Tanaka [Japon] ; Eisuke Inoue ; Daisuke Hoshi ; Yoko Shimizu ; Akiko Kobayashi ; Naoki Sugimoto ; Kumi Shidara ; Eri Sato ; Yohei Seto ; Ayako Nakajima ; Shigeki Momohara ; Atsuo Taniguchi ; Hisashi Yamanaka	Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
002277 (2014)	R. Ariza [Oman] ; A. Van Walsem [Oman] ; C. Canal [Oman] ; C. Roldán [Oman] ; L. Beteg N [Oman] ; I. Oyagüez [Oman] ; K. Janssen [Oman]	[Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain].
003519 (2012)	Alexander Diamantopoulos [Royaume-Uni] ; Maurizio Benucci ; Stefano Capri ; Wolfgang Berger ; Neil Wintfeld ; Giovanni Giuliani ; Walter Ricciardi	Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy.
003730 (2012)	Yee Chiu [Royaume-Uni] ; Andrew J. K. Ostor [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Katharina Sokoll [Royaume-Uni] ; Marina Anderson [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni] ; Patrick Gordon [Royaume-Uni] ; Sophia Steer [Royaume-Uni] ; Ian N. Bruce [Royaume-Uni]	Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Health Care Costs" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Health Care Costs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Health Care Costs
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021